Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001232524-14-000080
Filing Date
2014-08-05
Accepted
2014-08-05 17:24:15
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q jazz2014q2doc.htm 10-Q 1695732
2 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq22014ex311.htm EX-31.1 12940
3 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq22014ex312.htm EX-31.2 12126
4 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 jazzq22014ex321.htm EX-32.1 7939
  Complete submission text file 0001232524-14-000080.txt   10573269

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT jazz-20140630.xml EX-101.INS 1657658
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20140630.xsd EX-101.SCH 63675
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20140630_cal.xml EX-101.CAL 124517
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20140630_def.xml EX-101.DEF 304176
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20140630_lab.xml EX-101.LAB 801968
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20140630_pre.xml EX-101.PRE 467812
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 141017142
SIC: 2834 Pharmaceutical Preparations